A new daily diabetes and weight loss pill has launched in selected UK pharmacies. Foundayo offers an alternative for eligible patients who cannot or do not want to use injections. The Medicines and Healthcare products Regulatory Agency approved orforglipron, sold as Foundayo, on August 10. US pharmaceutical company Eli Lilly
